Drug intelligence / Profile preview

2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide

Development stage
Preclinical
Modality
Small Molecules
01

Overview

2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide is a small molecule that functions as an inhibitor of human Matrix Metalloproteinase 12 (MMP12). MMP12, also known as macrophage elastase, is an enzyme involved in the breakdown of extracellular matrix components, particularly elastin, and plays a role in tissue remodeling and inflammatory responses. By inhibiting MMP12 activity, this compound helps maintain the structural integrity of the extracellular matrix and reduces inflammation. It has been investigated in preclinical models for its potential therapeutic benefits in conditions such as chronic obstructive pulmonary disease (COPD), atherosclerosis, certain types of cancer, neurodegenerative diseases, and abdominal aortic aneurysms.

Other names
2-((4-fluorophenyl)sulfonylamino)-N-oxo-ethanamide2-(4-fluorobenzenesulfonamido)-N-oxoacetamideN~2~-[(4-fluorophenyl)sulfonyl]-N-oxoglycinamide4-fluoro-N-(2-nitroso-2-oxoethyl)benzenesulfonamide2-[(4-fluorophenyl)sulfonylamino]-N-oxoacetamide
02

Targets

MMP12 (Macrophage Metalloelastase)

Beyond the preview

Go deeper on 2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call